MINIject is iSTAR Medical’s innovative minimally invasive glaucoma surgery (MIGS) device for patients with open-angle glaucoma. It is currently the only commercially available MIGS implant targeting the supraciliary space globally, and delivers safe, meaningful, and sustained control of intraocular pressure (IOP).
The MINIject implant is made of proprietary Star material; a soft and flexible, medical-grade silicone. It has anti-fibrotic properties through its micro-pores, which enable bio-integration and a natural flow of fluid throughout the implant.
Three-year follow-up results presented at the 2023 World Glaucoma Congress demonstrate sustained, meaningful, mean IOP reduction of 36%, with 42% of patients medication-free.
Mean endothelial cell density loss at three years was 9% (less than for cataract surgery at two years).
Contact: istar-medical.com
